亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

3D System For Differentiation Of Oligodendocyte Precusors From Pluripotent Stem Cells

技术优势
Shortened differentiation protocolMore cellsReduction in cost
技术应用
Therapy for demyelinating diseasesResearch studies of human demyelinating diseases
详细技术说明
None
*Abstract

Cell replacement therapies using have long been thought to have the potential to treat demyelinating diseases such as multiple sclerosis or hypomyelinating leukodystrophies - as well as spinal cord and other CNS injuries that involve inflammation and loss of myelin. While pluripotent stem cells represent a potential source of readily available regenerative tissue, they require labor-intensive culturing to differentiate into target cell types.  Since Oligodendrocyte precursors cells (OPCs) can migrate, engraft and differentiate when experimentally transplanted onto unmyelinated axons, OPCs have been seen as the future of cell replacement therapies for demyelinating diseases.  However, as there is currently no reliable and sustainable source of transplantable OPCs, their therapeutic potential cannot be harnessed.

 

Researchers at the UC Berkeley have created a 3-dimensional, chemically defined biomaterial system for the large-scale differentiation of OPCs. By systematically optimized chemical cues, this strategy rapidly generated Olig2 and NKX2.2-positive cells with the same efficiency of other protocols, but in a shorter period of time (approximately 18 days instead of 30). This shortened 3D differentiation protocol, which results in up to 2-4 times more cells, enables a significant reduction in the cost of production of pre-OPCs.

 

*IP Issue Date
Apr 13, 2017
*Principal Investigation

Name: Gonçalo Morais Castro Rodrigues

Department:


Name: David Schaffer

Department:

申请号码
WO2017062374
其他

Additional Technologies by these Inventors


Tech ID/UC Case

25307/2016-018-0


Related Cases

2016-018-0

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备